Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

Mereo BioPharma (MREO)

Mereo BioPharma Group PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MREO
DateTimeSourceHeadlineSymbolCompany
15/05/202421:49Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:MREOMereo BioPharma Group PLC
15/05/202421:19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MREOMereo BioPharma Group PLC
15/05/202421:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MREOMereo BioPharma Group PLC
15/05/202421:01GlobeNewswire Inc.Mereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:MREOMereo BioPharma Group PLC
03/04/202412:30GlobeNewswire Inc.Mereo BioPharma to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:MREOMereo BioPharma Group PLC
27/03/202420:01GlobeNewswire Inc.Mereo BioPharma Reports Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:MREOMereo BioPharma Group PLC
05/03/202412:30GlobeNewswire Inc.Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Biopharma ConferenceNASDAQ:MREOMereo BioPharma Group PLC
09/02/202421:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
09/02/202421:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
09/02/202421:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
09/02/202421:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
06/02/202421:15Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MREOMereo BioPharma Group PLC
26/01/202421:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
26/01/202421:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
23/01/202421:16Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:MREOMereo BioPharma Group PLC
08/01/202412:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MREOMereo BioPharma Group PLC
08/01/202412:00GlobeNewswire Inc.Mereo BioPharma Provides Update on Pipeline Progress and Corporate DevelopmentsNASDAQ:MREOMereo BioPharma Group PLC
02/01/202421:20Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
02/01/202421:17Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
02/01/202421:16Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
02/01/202421:15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
02/01/202421:15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
02/01/202421:15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
02/01/202421:15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
18/12/202321:16Edgar (US Regulatory)Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend]NASDAQ:MREOMereo BioPharma Group PLC
18/12/202321:10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MREOMereo BioPharma Group PLC
29/11/202321:15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MREOMereo BioPharma Group PLC
16/11/202312:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MREOMereo BioPharma Group PLC
23/10/202321:08Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MREOMereo BioPharma Group PLC
23/10/202321:01GlobeNewswire Inc.Mereo BioPharma Reports on Recent Program Developments and Provides Financial UpdateNASDAQ:MREOMereo BioPharma Group PLC
 Showing the most relevant articles for your search:NASDAQ:MREO